Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 2
1976 6
1977 2
1978 2
1979 3
1980 11
1981 4
1982 8
1983 7
1984 9
1985 6
1986 6
1987 5
1988 9
1989 3
1990 2
1991 7
1992 5
1993 4
1995 2
1996 2
1997 1
1998 4
2000 2
2001 2
2002 1
2004 2
2005 1
2006 1
2007 1
2010 1
2011 1
2012 1
2015 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Disopyramide pharmacokinetics and bioavailability.
Dubetz DK, Brown NN, Hooper WD, Eadie MJ, Tyrer JH. Dubetz DK, et al. Br J Clin Pharmacol. 1978 Sep;6(3):279-81. doi: 10.1111/j.1365-2125.1978.tb04598.x. Br J Clin Pharmacol. 1978. PMID: 687507 Free PMC article. Clinical Trial. No abstract available.
Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration.
Pollick C. Pollick C. Am J Cardiol. 1988 Dec 1;62(17):1252-5. doi: 10.1016/0002-9149(88)90269-x. Am J Cardiol. 1988. PMID: 3057852 Clinical Trial.
Disopyramide was more effective than propranolol (p less than 0.01). ...Preejection period was lengthened from 93 +/- 35 ms with placebo to 119 +/- 25 ms with disopyramide, but was unchanged by propranolol at 98 +/- 23 ms. Disopyramide increased exercise dura …
Disopyramide was more effective than propranolol (p less than 0.01). ...Preejection period was lengthened from 93 +/- 35 ms with plac …
[Comparison of the efficacy of moricizine and disopyramide in the treatment of ventricular extrasystoles].
Fauchier JP, Babuty D, Rouesnel P, Cosnay P, Estepo J. Fauchier JP, et al. Arch Mal Coeur Vaiss. 1991 Apr;84(4):553-60. Arch Mal Coeur Vaiss. 1991. PMID: 1712193 Review. French.
Moricizine chlorhydrate (Ethmozine), a relatively unknown antiarrhythmic agent in France, is a derivative of Phenothiazine, related to the Vaughan-Williams Class IB drugs. A randomised, double-blind, crossover trial with Disopyramide 600 mg/day after a placebo period in 10 …
Moricizine chlorhydrate (Ethmozine), a relatively unknown antiarrhythmic agent in France, is a derivative of Phenothiazine, related to the V …
Disopyramide-pyridostigmine interaction: selective reversal of anticholinergic symptoms with preservation of antiarrhythmic effect.
Teichman SL, Ferrick A, Kim SG, Matos JA, Waspe LE, Fisher JD. Teichman SL, et al. J Am Coll Cardiol. 1987 Sep;10(3):633-41. doi: 10.1016/s0735-1097(87)80207-3. J Am Coll Cardiol. 1987. PMID: 3624669 Free article. Clinical Trial.
This double-blind, randomized, placebo crossover study was used to evaluate the effects of a cholinesterase inhibitor--slow-release pyridostigmine (180 mg orally every 12 hours)--on the anticholinergic and antiarrhythmic properties of disopyramide. Quantitative side effect …
This double-blind, randomized, placebo crossover study was used to evaluate the effects of a cholinesterase inhibitor--slow-release pyridost …
Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study.
Karlson BW, Torstensson I, Abjörn C, Jansson SO, Peterson LE. Karlson BW, et al. Eur Heart J. 1988 Mar;9(3):284-90. doi: 10.1093/oxfordjournals.eurheartj.a062498. Eur Heart J. 1988. PMID: 3289932 Clinical Trial.
After 1 month there was already a significant difference (P less than 0.01) between the two groups (disopyramide 70%, placebo 39%), a difference that was still remaining after 12 months (disopyramide 54%, placebo 30%). ...From the results of this study, disopyram …
After 1 month there was already a significant difference (P less than 0.01) between the two groups (disopyramide 70%, placebo 39%), a …
Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
Trimarco B, Volpe M, Ricciardelli B, Sacca' L, De Luca N, Rengo F, Condorelli M. Trimarco B, et al. Arch Int Pharmacodyn Ther. 1980 Dec;248(2):251-9. Arch Int Pharmacodyn Ther. 1980. PMID: 7013721 Clinical Trial.
Forty patients with serious lidocaine-responsive ventricular arrhythmias were randomly assigned to treatment with either oral disopyramide (100 mg 4 times daily) or mexiletine (200 mg 4 times daily) for 3 weeks. A satisfactory arrhythmias control (greater than 75 % reducti …
Forty patients with serious lidocaine-responsive ventricular arrhythmias were randomly assigned to treatment with either oral disopyramid …
Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
Tanabe T, Takahashi K, Yoshioka K, Goto Y. Tanabe T, et al. Int J Cardiol. 1991 Sep;32(3):303-12. doi: 10.1016/0167-5273(91)90292-w. Int J Cardiol. 1991. PMID: 1724233 Clinical Trial.
The efficacies and side effects of disopyramide and mexiletine used alone and in combination were assessed in 29 patients with chronic ventricular arrhythmias. ...The opposite was observed with mexiletine alone. QTc interval with disopyramide alone was significantly …
The efficacies and side effects of disopyramide and mexiletine used alone and in combination were assessed in 29 patients with chroni …
The anticholinergic side effects of disopyramide and controlled-release disopyramide.
Teichman S. Teichman S. Angiology. 1985 Nov;36(11):767-71. doi: 10.1177/000331978503601101. Angiology. 1985. PMID: 4061965 Clinical Trial.
A sustained-release form of pyridostigmine, an acetyl-cholinesterase inhibitor, has been shown to a) prevent the anticholinergic side effects of disopyramide when used prophylactically and b) to eliminate or attenuate these symptoms if they are already present. Pyridostigm …
A sustained-release form of pyridostigmine, an acetyl-cholinesterase inhibitor, has been shown to a) prevent the anticholinergic side effect …
126 results

Searches related to "disopyramide"